MedChem 2011 - Emerging Targets and Treatments:
Opportunities and Challenges for Drug Design
25/11/2011
08:00Registration
08:50Opening
09:00Translocator Protein as a Promising Target for Novel Anxiolytics
Prof. Federico DA SETTIMO
(UNIVERSITÀ DI PISA, Pisa, Italy)
09:50New Selective Androgen Receptor Modulators (SARM) for the Treatment of Cachexia
Dr Pierre DEPREZ
(GALAPAGOS, Romainville, France)
10:40Coffee Break
11:15Therapeutic Targeting of TLR Signalling
Dr Brian KEOGH
(OPSONA THERAPEUTICS LTD, Dublin 8, Ireland)
12:05Reversal of Tumoral Immune Resistance by Inhibition of Tryptophan 2,3-Dioxygenase (TDO): Discovery of an Orally Active TDO Inhibitor
Prof. Raphaël FREDERICK
(UCLOUVAIN, Bruxelles-Woluwé, Belgium)
12:25Sandwich Lunch
14:00Drug-to-Genome-to-Drug: Discovery and Optimisation of an Antimalarial Compound
Prof. Benoit DEPREZ
(UNIVERSITY OF LILLE 2, Lille, France)
14:50Can Medicinal Chemistry Solve Target Related Issues?
Dr Sandro BOLAND
(AMAKEM NV, Diepenbeek, Belgium)
15:10MASPIT, a Strategy for Small Molecule-Protein Interaction Mapping in Intact Human Cells
Dr Sam LIEVENS
(UGENT/VIB, Gent, Belgium)
15:30Coffee Break and Poster Session
16:05Targeting GSK-3 with ATP Non-Competitive Inhibitors: From the Bench to the Clinical Trials
Prof. Ana MARTINEZ
(INSTITUTO DE QUIMICA MEDICA-CSIC, Madrid, Spain)
16:55New Targets for the Treatment of HIV
Dr David PRYDE
(PFIZER GLOBAL R&D, Sandwich, United Kingdom)
17:45Closing Remarks
<Previous page


Sponsors

Sponsor of the pads

Media Partners